Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-01 Sale |
2024-04-02 6:07 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) |
View |
| 2024-03-15 Sale |
2024-03-19 4:27 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $20.1 | $33,487 | 119,709 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 5:38 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $18.37 | $30,604 | 121,375 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:16 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:15 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
9,589 | $17.29 | $165,794 | 2,480,671 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:14 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:14 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
22,844 | $17.62 | $402,420 | 711,090 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:26 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $18.42 | $30,688 | 123,041 (Direct) |
View |
| 2024-01-10 Sale |
2024-01-12 8:18 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 5:28 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
7,818 | $19.78 | $154,640 | 2,490,260 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:35 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
9,972 | $19.43 | $193,756 | 360,681 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:34 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:34 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
9,972 | $19.43 | $193,756 | 683,934 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:33 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
17,483 | $19.43 | $339,695 | 2,498,078 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-18 7:30 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $23.39 | $38,968 | 124,707 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-16 6:14 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $19.13 | $31,871 | 126,373 (Direct) |
View |
| 2023-10-16 Sale |
2023-10-18 4:44 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $20.66 | $34,420 | 128,039 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 4:45 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $23.62 | $39,348 | 129,705 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 5:36 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,522 | $23.17 | $58,435 | 640,186 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 5:30 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,522 | $23.22 | $58,561 | 316,933 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:34 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,478 | $22.6 | $56,003 | 319,455 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:33 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,478 | $22.59 | $55,978 | 642,708 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:32 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,309 | $22.59 | $52,160 | 2,426,041 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:31 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
1,419 | $22.6 | $32,069 | 995,799 (Indirect Direct) |
View |
| 2023-08-15 Sale |
2023-08-17 6:42 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $24.3 | $40,484 | 131,371 (Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 6:20 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,768 | $23.79 | $65,851 | 321,933 (Indirect Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 6:19 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,772 | $23.67 | $65,613 | 645,186 (Indirect Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 5:13 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,526 | $25.03 | $63,226 | 3,546,441 (Indirect Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 5:12 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,857 | $24.15 | $68,997 | 324,701 (Indirect Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 5:11 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,853 | $24.18 | $68,986 | 647,958 (Indirect Direct) |
View |
| 2023-07-17 Sale |
2023-07-19 5:10 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
19,702 | $29.8 | $587,157 | 719,748 (Indirect Direct) |
View |
| 2023-07-17 Sale |
2023-07-19 5:09 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $29.6 | $49,314 | 133,037 (Direct) |
View |
| 2023-06-28 Sale |
2023-06-30 5:21 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $29.84 | $49,709 | 134,703 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-20 6:28 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
50,000 | $31.4 | $1,570,000 | 3,548,967 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-29 Gift |
2024-03-29 5:59 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
40,000 | $0 | 2,440,671 (Indirect) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:48 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
50,000 | $0 | 879,012 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:48 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
50,000 | $0.68 | 879,012 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:57 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
214,880 | $0 | 855,066 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:57 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
214,880 | $0 | 531,813 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:56 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
358,080 | $0 | 2,784,121 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 5:13 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,526 | $0 | 3,546,441 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 5:13 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,526 | $0.68 | 3,546,441 (Indirect) |
View |
| 2023-07-17 Exercise |
2023-07-19 5:10 pm |
N/A 2027-03-07 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $0 | 719,748 (Direct) |
View |
| 2023-07-17 Exercise |
2023-07-19 5:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
10,000 | $5.28 | 719,748 (Indirect) |
View |
| 2023-06-16 Exercise |
2023-06-20 6:28 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
50,000 | $0 | 3,548,967 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-20 6:28 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
50,000 | $0.68 | 3,548,967 (Indirect) |
View |
| 2023-06-01 Option Award |
2023-06-05 6:08 pm |
N/A 2033-06-01 |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
16,865 | $0 | 25,362 (Direct) |
View |